Intravitreal Injection Site and Perceived Pain
NCT05640895 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53
Last updated 2025-01-31
Summary
The objective of this study is to explore the perception of pain during intravitreal injection related to the distance of the entry site from the limbus.
Conditions
Interventions
- PROCEDURE
-
Intravitreal injection site
Intravitreal injections will be made at varying sites; patients will report on pain perception
Sponsors & Collaborators
-
The University of Texas Medical Branch, Galveston
lead OTHER
Principal Investigators
-
Touka K Banaee, MD · University of Texas
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-11-14
- Primary Completion
- 2023-12-18
- Completion
- 2024-09-09
Countries
- United States
Study Locations
More Related Trials
-
Intravitreal Injections by Nurses and Physicians Compared
NCT02359149 ·Status: COMPLETED ·Phase: NA
-
Intravitreal Conbercept Injection in Patients With Myopic Choroidal Neovascularization
NCT03971162 ·Status: COMPLETED ·Phase: NA
-
The Effectiveness of Intravitreal Avastin Injection for CRVO
NCT01678248 ·Status: UNKNOWN
-
Vascular Endothelial Growth Factor (VEGF) in Uveitis
NCT00001738 ·Status: COMPLETED
-
Optic Nerve and Retinal Functions With Bevacizumab
NCT01361828 ·Status: COMPLETED
-
Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment
NCT00417833 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Effect of Intravitreal Bevacizumab on Corneal Endothelium
NCT01726790 ·Status: UNKNOWN
-
Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal Bevacizumab
NCT00864838 ·Status: COMPLETED ·Phase: PHASE2
-
Study on the Biomarkers of Anti-VEGF Treatment for Choroidal Neovascularization
NCT06243406 ·Status: NOT_YET_RECRUITING
-
The Effect of Conbercept Injection Through Different Routes for Neovascular Glaucoma
NCT03154892 ·Status: COMPLETED ·Phase: NA
-
Short-term Effect of Rho-kinase Inhibitor on Retinal Circulation
NCT04234932 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia
NCT00967850 ·Status: COMPLETED ·Phase: PHASE3
-
Brolucizumab for CNV Associated With Pathologic Myopia
NCT04976244 ·Status: UNKNOWN ·Phase: NA
-
Aqueous Vascular Endothelial Growth Factor (VEGF) Levels in Type 3 Neovascularization
NCT01350323 ·Status: COMPLETED ·Phase: NA
-
Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery
NCT00468429 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Intravitreal Avastin on the Retina Measured by Electroretinogram
NCT00478530 ·Status: COMPLETED ·Phase: NA
-
Application of Intravitreal Conbercept Injection as a Primary Treatment for Exudative Circumscribed Choroidal Haemangioma
NCT03973125 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Intravitreal Bevacizumab and Low Fluence Photodynamic Therapy
NCT00802126 ·Status: COMPLETED ·Phase: PHASE1
-
Intravitreal Bevacizumab for Inflammatory Neovascular Membranes
NCT00407121 ·Status: WITHDRAWN ·Phase: PHASE3
-
Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy
NCT01025934 ·Status: COMPLETED ·Phase: PHASE4
-
Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization
NCT02033018 ·Status: UNKNOWN ·Phase: PHASE4
-
Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD
NCT00684853 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Intravitreal Bevacizumab on Early Post-Vitrectomy Hemorrhage in Diabetic Patients
NCT00524875 ·Status: UNKNOWN ·Phase: NA
-
Central Vein Occlusion Study (CVOS)
NCT00000131 ·Status: COMPLETED ·Phase: PHASE3
-
Neovascular Morphology and Persistent Disease Activity Among Patients With NV AMD
NCT02367365 ·Status: COMPLETED